Publications

Selected items (last five years)

  • Jon Allard, Adrian Sellers, William Henley, Brendan McLean, Mary Parrett, Sanjeev Rajakulendran, Lance Watkins, Melissa Maguire, Shan Ellawela, Phil Tittensor, Juliet Bransgrove, Arjune Sen, Rajiv Mohanraj, Many Bagary, Sunil Ram, Nathan Vernon, Sandy Baldwin, Jagdish Gill, Rohit Shankar. Efficacy and tolerability of levetiracetam in people with and without intellectual disabilities: a naturalistic case control study. Seizure. 2024. doi:10.1016/j.seizure.2024.05.010.

  • Fairclough S, Chumas P, Goodden J, Maguire M, Mathew RK. Motor seizures confer overall survival benefit in who grade 2 glioma. Epilepsia. 2024 Mar 20. doi: 10.1111/epi.17956

  • Mehboob S, Sureshkumar SM, Fernandes L, Wright E, Ray M, Goodden J, Maguire M. Refractory status epilepticus arrested by vagus nerve stimulation. Pract Neurol. 2024 Mar 19;24(2):129-133.

  • Fairclough S, Goodden J, Chumas P, Mathew R, Maguire M. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure. Epilepsia. 2023 Jan 13.

  • Mitchell JW, Noble A, Baker G, Batchelor R, Brigo F, Christensen J, French J, Gil-Nagel A, Guekht A, Jette N, Kälviäinen R, Leach JP, Maguire M, O'Brien T, Rosenow F, Ryvlin P, Tittensor P, Tripathi M, Trinka E, Wiebe S, Williamson PR, Marson T. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET). Trials. 2022 Nov 17;23(1):943.

  • Maguire MJ. Wired for sound: The effect of sound on the epileptic brain. Seizure. 2022 Nov;102:22-31. doi: 10.1016/j.seizure.2022.09.016.

  • Shakeshaft A, Laiou P, Abela E, Stavropoulos I, Richardson MP, Pal DK; BIOJUME Consortium. Heterogeneity of resting-state EEG features in juvenile myoclonic epilepsy and controls. Brain Commun. 2022 Jul 8;4(4):fcac180.

  • Williams S, Southall C, Haley S, Ba Dhafari T, Kemp S, Relton SD, Alty JE, Johnson O, Graham CD, Maguire M. To the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders. J Neurol Sci. 2022 Jun 15;437:120251.

  • Tanti MJ, Maguire MJ, Warren DJ, Bamford J. Late onset AMACR deficiency with metabolic stroke-like episodes and seizures. BMJ Case Rep. 2022 Apr 15;15(4):e247964.

  • Maguire M. Response to "Perampanel and pregnancy: Could experience be a gloomy lantern that does not even illuminate its bearer?". Epilepsy Behav. 2022 Apr;129:108654.

  • Maguire M, Ben-Menachem E, Patten A, Malhotra M, Ngo LY. A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy. Epilepsy Behav. 2022 Jan;126:108483.

  • Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Health Technol Assess. 2021 Dec;25(75):1-134.

  • Maguire MJ, Nevitt SJ. Treatments for seizures in catamenial (menstrual-related) epilepsy. Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225.

  • Tanti M, Cosgrove J, Kelleher C, Jones R, Maguire M. Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital. Clin Med (Lond). 2021 May;21(3):189-194.

  • Maguire MJ, Marson AG, Nevitt SJ. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2021 Apr 16;4(4):CD010682.

  • Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021 Apr 10;397(10282):1375-1386.

  • Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021 Apr 10;397(10282):1363-1374.

  • Bresnahan R, Gianatsi M, Maguire MJ, Tudur Smith C, Marson AG. Vigabatrin add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2020 Jul 30;7(7):CD007302.

  • Goldstein LH, Robinson EJ, Mellers JDC, Stone J, Carson A, Reuber M, Medford N, McCrone P, Murray J, Richardson MP, Pilecka I, Eastwood C, Moore M, Mosweu I, Perdue I, Landau S, Chalder T; CODES study group. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry. 2020 Jun;7(6):491-505.

  • Watkins L, O'Dwyer M, Oak K, Lawthom C, Maguire M, Thomas R, Shankar R. The evidence for switching dibenzazepines in people with epilepsy. Acta Neurol Scand. 2020 Aug;142(2):121-130.

  • Maguire MJ, Jackson CF, Marson AG, Nevitt SJ. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP). Cochrane Database Syst Rev. 2020 Apr 2;4(4):CD011792.

  • Adewusi J, Burness C, Ellawela S, Emsley H, Hughes R, Lawthom C, Maguire M, McLean B, Mohanraj R, Oto M, Singhal S, Reuber M. Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation. Epilepsy Behav. 2020 May;106:106967.

  • Allard J, Henley W, Mclean B, Sellers A, Hudson S, Rajakulendran S, Pace A, Pashley S, Maguire M, Mohan M, Ellawela S, Tittensor P, Ram S, Bagary M, Shankar R. Lacosamide in the general population and in people with intellectual disability: Similar responses? Seizure. 2020 Feb 19;76:161-166.

  • Maguire M. The psychopharmacology of epilepsy. Handb Clin Neurol. 2019;165:207-227.

  • Goldstein LH, Robinson EJ, Reuber M, Chalder T, Callaghan H, Eastwood C, Landau S, McCrone P, Medford N, Mellers JDC, Moore M, Mosweu I, Murray J, Perdue I, Pilecka I, Richardson MP, Carson A, Stone J; CODES Study Group. Characteristics of 698 patients with dissociative seizures: A UK multicenter study. Epilepsia. 2019 Nov;60(11):2182-2193.

  • Foo EC, Geldard J, Peacey C, Wright E, Eltayeb K, Maguire M. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability. Epilepsy Behav. 2019 Oct;99:106505.

  • Maguire M, Singh J, Marson A. Epilepsy and psychosis: a practical approach. Pract Neurol. 2018 Apr;18(2):106-114.

  • Hale MD, Zaman A, Morrall MCHJ, Chumas P, Maguire MJ. A Novel Functional Magnetic Resonance Imaging Paradigm for the Preoperative Assessment of Auditory Perception in a Musician Undergoing Temporal Lobe Surgery. World Neurosurg. 2018 Mar;111:63-67.